c-Myc inhibitors (NantCancerStemCell)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namec-Myc inhibitors (NantCancerStemCell)
Drug Alias NameMyc inhibitors (Scripps Research Institute)KJ-Pyr-9Myc inhibitors (Sorrento)c-Myc inhibitors (Sorrento/NantBioScience)PMC2-51
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNantCancerStemCell LLCNantBio IncSorrento Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A